Sanofi ejects chief executive ViehbacherChris Viehbacher has departed from his role as chief executive of Sanofi after the company’s board voted to Share XSanofi ejects chief executive Viehbacherhttps://pharmaphorum.com/news/sanofi-ejects-chief-executive-viehbacher/
AZ’s ovarian cancer drug Lynparza recommended in EuropeA novel PARP inhibitor has received a positive opinion for treating ovarian cancer from the European Medicines Agency’s Share XAZ’s ovarian cancer drug Lynparza recommended in Europehttps://pharmaphorum.com/news/astrazeneca-ovarian-cancer-parp-inhibitor-recommended-by-ema/
Merck’s Keytruda granted breakthrough status in lung cancerMerck’s newly launched immunotherapy treatment Keytruda has just been granted special fast-track status for use in non-small cell Share XMerck’s Keytruda granted breakthrough status in lung cancerhttps://pharmaphorum.com/news/mercks-keytruda-gains-breakthrough-status-in-lung-cancer/
Juncker backtracks on EU plans for pharmaConcerns that the European pharma sector would be monitored for its contribution to business – and not health – Share XJuncker backtracks on EU plans for pharmahttps://pharmaphorum.com/news/juncker-backtracks-on-eu-plans-for-pharma/
EU consortium to combat antibiotic resistanceA new consortium to tackle antibiotic resistance has received an injection of €9.4 million from the European Union’s Share XEU consortium to combat antibiotic resistancehttps://pharmaphorum.com/news/eu-consortium-to-combat-antibiotic-resistance/
Novartis sells flu vaccine business to CSL for $275mNovartis has found a buyer for its flu vaccines business, wrapping up the deal which sees it selling Share XNovartis sells flu vaccine business to CSL for $275mhttps://pharmaphorum.com/news/novartis-sells-flu-vaccine-business-to-csl-for-275m/
Probiodrug IPO raises €22.5 million to fund Alzheimer’s candidatesProbiodrug has successfully completed an Initial Public Offering (IPO) and will begin trading on Euronext Amsterdam on Monday Share XProbiodrug IPO raises €22.5 million to fund Alzheimer’s candidateshttps://pharmaphorum.com/news/probiodrug-ipo-raises-22-5-million-to-fund-alzheimer-s-candidates/
Increase NHS funding or face £30 billion shortfall, politicians warnedThe health service in England will not be able to cope without billions in extra funding over the Share XIncrease NHS funding or face £30 billion shortfall, politicians warnedhttps://pharmaphorum.com/news/increase-funding-or-face-30-bn-nhs-shortfall-politicians-warned/
NICE draft guidance recommends Bayer’s Xarelto post heart attackDraft guidance from UK health watchdog NICE recommends Bayer’s rivaroxaban (Xarelto) for preventing blood clots in people who Share XNICE draft guidance recommends Bayer’s Xarelto post heart attackhttps://pharmaphorum.com/news/nice-draft-guidance-recommends-bayer-s-xarelto-post-heart-attack/
